Start for free

Anthem Biosciences Limited

NSE: ANTHEMHealthcare

Anthem Biosciences Limited Share Price & Analysis

₹934.05−1.75%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹934.05−1.75%
Open
₹960.80
High
₹960.80
Low
₹926.80
Close
₹934.05
52W High
₹974.00
52W Low
₹579.00
Volume
873K
Lot Size
1
Sector
Healthcare
Market Cap
₹53K Cr
Face Value
₹2
Large CapNIFTY 500Nifty Midcap 150

Price Chart

Candle
Range

Fundamentals

P/E
88.70
Sector P/E
54.70
P/B
13.94
EPS
₹10.41
ROE
22.30%
ROCE
30.40%
D/E Ratio
0.02
Div Yield
0.21%
Book Value
₹54.20

Strengths

  • Excellent return on equity (ROE 22.3%)
  • Efficient capital deployment (ROCE 30.4%)
  • Virtually debt-free

Concerns

  • Premium to sector peers (P/E 88.7x vs industry 54.7x)
  • High premium to book value (P/B 13.9x)

Peer Comparison

CompanyCMPMkt CapP/EP/BROE %ROCE %D/E
SUNPHARMA
Sun Pharmaceutical Industries Limited
₹1,899
₹4.6L Cr36.15.461620.50.07
DIVISLAB
Divi's Laboratories Limited
₹9,100
₹2.4L Cr81.114.4216.5220.01
TORNTPHARM
Torrent Pharmaceuticals Limited
₹4,857
₹1.8L Cr82.819.5827.415.20.33
APOLLOHOSP
Apollo Hospitals Enterprise Limited
₹8,650
₹1.2L Cr59.113.1321.217.40.88
CIPLA
Cipla Limited
₹1,385
₹1.1L Cr31.33.2511.615.50.01
ZYDUSLIFE
Zydus Lifesciences Limited
₹1,120
₹1.1L Cr234.1621.221.10.38
LAURUSLABS
Laurus Labs Limited
₹1,840
₹99K Cr90.918.7418.317.80.46

Showing 7 peers in the same sector · Sorted by market cap

Shareholding Pattern

ANTHEM · as of Jun 2026

Promoters71.42%3.25pp
FII2.57%1.29pp
DII13.48%1.93pp
Public12.52%0.04pp
CategorySep 2025Dec 2025Mar 2026Jun 2026
Promoters74.69%74.69%74.67%71.42%
FII1.66%1.37%1.28%2.57%
DII7.21%7.60%11.55%13.48%
Public16.42%16.34%12.48%12.52%

Corporate Events

To consider and approve the financial results for the period ended Jun 30, 2026

Results20 Jul 2026

Dividend - Rs 2 Per Share

Record: 25 Jun 2026

Dividend24 Jun 2026

Latest News

All news

Anthem Biosciences receives credit rating update

*Anthem Biosciences receives credit rating update.* The company's latest credit assessment has been filed with the exchange. **No financial figures or rating specifics** were disclosed in the headline. This routine corporate filing may be monitored for future borrowing cost implications. 📊 *STOCKS:* ANTHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CreditRating

NSE Filing3 Jul
High Impact

Anthem Biosciences shares may see low trading interest

*Anthem Biosciences shares may see low trading interest* as the update pertains only to the annual report filing. The disclosure is routine, made under Regulation 36(1)(b) of LODR. No financial or operational updates were provided. Volume and price movement are expected to remain unaffected. 📊 *STOCKS:* ANTHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #RegulatoryFiling

NSE Filing8 Jul
Low Impact

Anthem Biosciences announces 20th AGM date

Anthem Biosciences has issued a pre-dispatch intimation for its 20th Annual General Meeting. The notice was published as part of regulatory requirements. No financial figures or strategic updates were disclosed. Shareholders are advised to review the notice for meeting details. 📊 *STOCKS:* ANTHEM | 🏢 *SECTOR:* Pharma | #LOWIMPACT #AGM

NSE Filing29 Jun
Low Impact

Financials

Quarterly Results

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue
₹611 Cr
44.4%
₹423 Cr
23.1%
₹550 Cr
1.9%
₹540 Cr
11.8%
₹483 Cr
3.0%
₹498 Cr
5.1%
₹525 Cr
54.9%
₹339 Cr
Op. Profit
₹267 Cr
70.1%
₹157 Cr
28.0%
₹218 Cr
14.1%
₹191 Cr
2.1%
₹195 Cr
21.9%
₹160 Cr
17.9%
₹195 Cr
61.2%
₹121 Cr
OPM
44.0%
18.9%
37.0%
7.5%
40.0%
14.3%
35.0%
12.5%
40.0%
25.0%
32.0%
13.5%
37.0%
2.8%
36.0%
Net Profit
₹190 Cr
104.3%
₹93 Cr
46.2%
₹173 Cr
27.2%
₹136 Cr
63.9%
₹83 Cr
33.1%
₹124 Cr
23.5%
₹162 Cr
97.6%
₹82 Cr
EPS (₹)
3.38
104.8%
1.65
46.6%
3.09
27.7%
2.42
63.5%
1.48
33.3%
2.22
23.4%
2.9
97.3%
1.47

Values in ₹ Cr · Source: Screener.in

Annual Profit & Loss

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue
₹2.1K Cr
15.1%
₹1.8K Cr
30.0%
₹1.4K Cr
34.2%
₹1.1K Cr
14.1%
₹1.2K Cr
11.6%
₹1.1K Cr
74.2%
₹633 Cr
Expenses
₹1.3K Cr
10.0%
₹1.2K Cr
28.3%
₹914 Cr
46.0%
₹626 Cr
6.0%
₹666 Cr
4.2%
₹695 Cr
54.1%
₹451 Cr
Op. Profit
₹834 Cr
24.1%
₹672 Cr
32.8%
₹506 Cr
17.4%
₹431 Cr
23.7%
₹565 Cr
38.5%
₹408 Cr
124.2%
₹182 Cr
OPM
39.0%
8.3%
36.0%
0.0%
36.0%
12.2%
41.0%
10.9%
46.0%
24.3%
37.0%
27.6%
29.0%
Other Income
₹131 Cr
54.1%
₹85 Cr
34.9%
₹63 Cr
54.7%
₹139 Cr
183.7%
₹49 Cr
32.4%
₹37 Cr
76.2%
₹21 Cr
Interest
₹7 Cr
36.4%
₹11 Cr
10.0%
₹10 Cr
11.1%
₹9 Cr
10.0%
₹10 Cr
41.2%
₹17 Cr
15.0%
₹20 Cr
Depreciation
₹134 Cr
50.6%
₹89 Cr
8.5%
₹82 Cr
28.1%
₹64 Cr
10.3%
₹58 Cr
6.5%
₹62 Cr
0.0%
₹62 Cr
PBT
₹824 Cr
25.4%
₹657 Cr
37.7%
₹477 Cr
4.0%
₹497 Cr
9.0%
₹546 Cr
49.2%
₹366 Cr
202.5%
₹121 Cr
Tax %
28.0%
9.7%
31.0%
34.8%
23.0%
0.0%
23.0%
11.5%
26.0%
0.0%
26.0%
13.0%
23.0%
Net Profit
₹592 Cr
31.3%
₹451 Cr
22.9%
₹367 Cr
4.7%
₹385 Cr
5.2%
₹406 Cr
49.8%
₹271 Cr
191.4%
₹93 Cr
EPS (₹)
10.54
30.6%
8.07
22.8%
6.57
2.7%
6.75
98.5%
462.09
44.5%
319.74
189.0%
110.62
Div Payout
19.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%

Values in ₹ Cr · Source: Screener.in

Balance Sheet

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Liabilities
Equity Capital
₹112 Cr
0.0%
₹112 Cr
0.0%
₹112 Cr
1.8%
₹114 Cr
1166.7%
₹9 Cr
12.5%
₹8 Cr
0.0%
₹8 Cr
Reserves
₹2.9K Cr
27.5%
₹2.3K Cr
26.8%
₹1.8K Cr
11.4%
₹1.6K Cr
20.9%
₹1.3K Cr
94.2%
₹693 Cr
67.8%
₹413 Cr
Borrowings
₹54 Cr
52.2%
₹113 Cr
52.7%
₹239 Cr
89.7%
₹126 Cr
260.0%
₹35 Cr
65.0%
₹100 Cr
37.1%
₹159 Cr
Other Liabilities
₹333 Cr
17.3%
₹284 Cr
20.9%
₹235 Cr
58.8%
₹148 Cr
35.1%
₹228 Cr
1.7%
₹232 Cr
12.1%
₹207 Cr
Total Liabilities
₹3.4K Cr
22.1%
₹2.8K Cr
17.1%
₹2.4K Cr
19.1%
₹2.0K Cr
24.4%
₹1.6K Cr
56.6%
₹1.0K Cr
31.4%
₹787 Cr
Assets
Fixed Assets
₹783 Cr
11.1%
₹705 Cr
46.0%
₹483 Cr
7.6%
₹449 Cr
36.5%
₹329 Cr
8.9%
₹361 Cr
18.0%
₹306 Cr
CWIP
₹264 Cr
11.1%
₹297 Cr
13.9%
₹345 Cr
110.4%
₹164 Cr
6.5%
₹154 Cr
710.5%
₹19 Cr
62.0%
₹50 Cr
Investments
₹1.0K Cr
132.6%
₹433 Cr
8.3%
₹472 Cr
5.4%
₹499 Cr
82.8%
₹273 Cr
30.6%
₹209 Cr
111.1%
₹99 Cr
Other Assets
₹1.4K Cr
0.1%
₹1.4K Cr
24.9%
₹1.1K Cr
21.8%
₹902 Cr
4.5%
₹863 Cr
93.9%
₹445 Cr
33.6%
₹333 Cr
Total Assets
₹3.4K Cr
22.1%
₹2.8K Cr
17.1%
₹2.4K Cr
19.1%
₹2.0K Cr
24.4%
₹1.6K Cr
56.6%
₹1.0K Cr
31.4%
₹787 Cr

Values in ₹ Cr · Source: Screener.in

Cash Flow Statement

ItemMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating CF
₹844 Cr
211.4%
₹271 Cr
93.6%
₹140 Cr
54.2%
₹306 Cr
8.1%
₹333 Cr
19.8%
₹278 Cr
67.5%
₹166 Cr
Investing CF
₹-702 Cr
377.6%
₹-147 Cr
33.5%
₹-221 Cr
41.2%
₹-376 Cr
83.4%
₹-205 Cr
4.6%
₹-196 Cr
79.8%
₹-109 Cr
Financing CF
₹-40 Cr
70.6%
₹-136 Cr
76.6%
₹-77 Cr
220.3%
₹64 Cr
64.6%
₹181 Cr
387.3%
₹-63 Cr
31.3%
₹-48 Cr
Net Cash Flow
₹103 Cr
958.3%
₹-12 Cr
92.4%
₹-158 Cr
2533.3%
₹-6 Cr
101.9%
₹308 Cr
1611.1%
₹18 Cr
100.0%
₹9 Cr
Free Cash Flow
₹637 Cr
5208.3%
₹12 Cr
107.7%
₹-156 Cr
239.3%
₹112 Cr
63.5%
₹307 Cr
93.1%
₹159 Cr
33.6%
₹119 Cr

Values in ₹ Cr · Source: Screener.in

Key Ratios History

MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Debtor Days
101d
13.5%
89d
29.4%
126d
32.6%
95d
2.1%
97d
15.5%
84d
37.7%
61d
Inventory Days
56d
66.5%
167d
29.5%
129d
7.2%
139d
167.3%
52d
79.3%
29d
84.4%
186d
Days Payable
34d
37.0%
54d
11.5%
61d
20.8%
77d
54.0%
50d
0.0%
50d
42.5%
87d
Cash Conv. Cycle
124d
38.6%
202d
4.7%
193d
23.7%
156d
57.6%
99d
57.1%
63d
60.6%
160d
Working Capital Days
92d
31.3%
134d
4.7%
128d
14.3%
112d
49.3%
75d
177.8%
27d
35.0%
20d
ROCE
30.0%
7.1%
28.0%
16.7%
24.0%
14.3%
28.0%
45.1%
51.0%
7.3%
55.0%
—

Source: Screener.in · Lower days = better efficiency

About Anthem Biosciences Limited

Incorporated in 2006, Anthem Biosciences Ltd is in the business of providing CRDMO services and the manufacture and sale of specialty ingredients.[1]

HealthcarePharmaceuticals & Biotechnology

Related Analysis

Same Sector

ALKEMAlkem Laboratories LimitedNeutralAPOLLOHOSPApollo Hospitals Enterprise LimitedNeutralAUROPHARMAAurobindo Pharma LimitedNeutralBIOCONBiocon LimitedNeutralCIPLACipla LimitedNeutral

Frequently Asked Questions

What is Anthem Biosciences Limited share price today?
Anthem Biosciences Limited (ANTHEM) is currently trading at ₹934.05 on NSE, down 1.75% as of the last market session. Prices update daily after market close on MarketNetra.
Is Anthem Biosciences Limited available in F&O (Futures & Options)?
Yes, Anthem Biosciences Limited (ANTHEM) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Anthem Biosciences Limited 52-week high and low?
Anthem Biosciences Limited's 52-week high is ₹974 and the 52-week low is ₹579. The current price of ₹934.05 is 4.1% below the 52W high.
What is Anthem Biosciences Limited P/E ratio?
Anthem Biosciences Limited's current P/E ratio is 88.7. This indicates the market is paying ₹88.7 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Anthem Biosciences Limited options?
Anthem Biosciences Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ANTHEM options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.